These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 7907607)

  • 1. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
    Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G
    J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological heterogeneity of diffuse mixed small and large cell non-Hodgkin's lymphomas assessed by DNA flow cytometry and Ki67.
    Palestro G; Pich A; Chiusa L; Geuna M; Ponti R; Kerim S; Novero D; Valente G
    Leuk Lymphoma; 1995 Nov; 19(5-6):467-72. PubMed ID: 8590848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki67) in non-Hodgkin's lymphomas.
    Czader M; Porwit A; Tani E; Ost A; Mazur J; Auer G
    Mod Pathol; 1995 Jan; 8(1):51-8. PubMed ID: 7731942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferative activity assessed by anti-PCNA and Ki67 monoclonal antibodies in canine testicular tumours.
    Sarli G; Benazzi C; Preziosi R; Marcato PS
    J Comp Pathol; 1994 May; 110(4):357-68. PubMed ID: 7914524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between PCNA and AgNOR scores in non-Hodgkin's lymphomas using sequential staining technique.
    Smith FG; Murray PG; Crocker J
    J Clin Pathol; 1993 Jan; 46(1):28-31. PubMed ID: 8094401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MIB-1 and S-phase cell fraction predict survival in non-Hodgkin's lymphomas.
    Mochen C; Giardini R; Costa A; Silvestrini R
    Cell Prolif; 1997 Jan; 30(1):37-47. PubMed ID: 9332493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen.
    Yu CC; Dublin EA; Camplejohn RS; Levison DA
    Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections.
    Cattoretti G; Becker MH; Key G; Duchrow M; Schlüter C; Galle J; Gerdes J
    J Pathol; 1992 Dec; 168(4):357-63. PubMed ID: 1484317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of labelling by bromodeoxyuridine, MIB-1, and proliferating cell nuclear antigen in gastric mucosal biopsy specimens.
    Lynch DA; Clarke AM; Jackson P; Axon AT; Dixon MF; Quirke P
    J Clin Pathol; 1994 Feb; 47(2):122-5. PubMed ID: 7907613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract.
    Lee CS
    Cancer; 1996 Nov; 78(9):1881-7. PubMed ID: 8909306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative assessment of proliferating cell nuclear antigen, c-myc p62, and nucleolar organizer region staining in non-Hodgkin's lymphomas: a histochemical and immunohistochemical study of 200 cases.
    Korkolopoulou P; Patsouris E; Pangalis G; Tsenga A; Elemenoglou J; Thomas-Tsangli E; Spandidos D; Kittas C
    Hum Pathol; 1993 Apr; 24(4):371-7. PubMed ID: 7684020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of proliferative grade in glial neoplasms using antibodies to the Ki-67 defined antigen and PCNA in formalin fixed, deparaffinized tissues.
    Hoyt JW; Gown AM; Kim DK; Berger MS
    J Neurooncol; 1995; 24(2):163-9. PubMed ID: 7562003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analysis of cellular proliferative activity in 35 T-cell non-Hodgkin's lymphomas. Use of proliferating cell nuclear antigen and Ki-67 (MIB-1) antibodies and nucleolar organizer regions.
    Caulet-Maugendre S; Patey M; Granier E; Joundi A; Gentile A; Caulet T
    Anal Quant Cytol Histol; 1996 Oct; 18(5):337-44. PubMed ID: 8908304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index.
    Khine MM; Aung W; Sibbons PD; Howard CV; Clapham E; McGill F; Van Velzen D
    Lab Invest; 1994 Jan; 70(1):125-9. PubMed ID: 7905542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of proliferating cell fraction determined by monoclonal antibody to M1-subunit ribonucleotide reductase and Ki-67 in relation to p53 protein expression in fine-needle aspirates from non-Hodgkin's lymphomas.
    Sviatoha V; Tani E; Rassidakis G; Tribukait B; Kleina R; Skoog L
    Cytopathology; 2000 Oct; 11(5):290-301. PubMed ID: 11014656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferative activity in non-Hodgkin's lymphomas. A comparison of the bromodeoxyuridine labeling index with PCNA immunostaining and quantitative image analysis.
    Sebo TJ; Roche PC; Witzig TE; Kurtin PJ
    Am J Clin Pathol; 1993 Jun; 99(6):668-72. PubMed ID: 8100680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferating cell nuclear antigen in archival surgical specimens of malignant lymphoma and metastatic carcinoma: immunohistochemical and flow cytometric analysis.
    Gorczyca W; Kram A; Tuziak T; Darzynkiewicz Z; Melamed MR
    Patol Pol; 1993; 44(3):121-8. PubMed ID: 7902557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53, c-myc p62 and proliferating cell nuclear antigen (PCNA) expression in non-Hodgkin's lymphomas.
    Korkolopoulou P; Oates J; Kittas C; Crocker J
    J Clin Pathol; 1994 Jan; 47(1):9-14. PubMed ID: 7907610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth fraction in non-small cell lung cancer estimated by proliferating cell nuclear antigen and comparison with Ki-67 labeling and DNA flow cytometry data.
    Fontanini G; Pingitore R; Bigini D; Vignati S; Pepe S; Ruggiero A; Macchiarini P
    Am J Pathol; 1992 Dec; 141(6):1285-90. PubMed ID: 1361306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/Cyclin 19A2. Correlation with Ki-67 labeling.
    Kamel OW; LeBrun DP; Davis RE; Berry GJ; Warnke RA
    Am J Pathol; 1991 Jun; 138(6):1471-7. PubMed ID: 1675840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.